374 Clinical, pharmacokinetic (PK) and pharmacodynamic (PD) results of first-in-man phase I trial of the orally available MEK-inhibitor MSC1936369 (AS703026) in patients (pts) with advanced solid tumors
| Autor: | Awada, A., Houedé, N., Delord, J.P., Dubuisson, M., Italiano, A., Bergé, Y., Faivre, S., Taama, A., Lüpfert, C., Raymond, E. |
|---|---|
| Zdroj: | In EJC Supplements 2010 8(7):118-118 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect